New drug acts like a "guided missile" to target cancer cells
A trial for the drug labeled DS-8201 was tested in 184 patients.
AstraZeneca
Senators grill pharma executives over rising drug prices
On average, Americans spent $1,162 per person on prescription drugs
FDA approves first drug for inherited breast cancer
AstraZeneca PLC's Lynparza is for patients with inherited BRCA gene mutations who have undergone chemotherapy
AstraZeneca cancer drug letdown slams stock price
Analysts' hopes for a future blockbuster were dashed as a clinical trial fails to improve patients' survival
Pfizer M&A blitz could heighten investor interest in biotechnology sector
Drug company's buying spree could be harbinger of more deals to come, according to at least one market observer
California couple at center of surrogacy scandal arrested
Live
Iran's Houthi allies deny losing ground as Mideast crisis engulfs Yemen
Investigation
The life and travels of an alleged Chinese agent in the U.S.
Eva Marie Saint, "North by Northwest" star, dies at 102
Olympian accused of damaging Reflecting Pool seeks probe of potential misconduct
Christa Pike is conscious, speaking after botched execution, attorneys say
Ex-CIA official found with $40 million in gold bars admits to sprawling scheme
Exclusive
Former Cornell frat members ask university to clear their names
